知镜 Cognispect · 医学文献与研究工作台

Natural polysaccharides targeting gut microbiota in renal fibrosis: Novel molecular mechanisms and therapeutic strategies.

Yu QQ, Li X, Fang HB, Zhang YL, Yang J, Miao H, Liu LM, Zhao YY.
Microbiological research · 2026-11-09 · PMID 43025159

文献摘要

Kidney disease, including acute kidney injury (AKI) and chronic kidney disease (CKD), represent a major global health burden and are associated with substantial morbidity and mortality. AKI is an overwhelming complication of acute disease that leads to the CKD development and ultimately progresses to end-stage renal disease. AKI and CKD are inter-related clinical and pathophysiological disorders. Current treatments, including dialysis and transplantation, are costly and not curative. Natural polysaccharides, widely distributed in medicinal plants and fungi, are important active components with broad healthcare applications. As a natural modulator of gut microbiota (GM), natural polysaccharides play an important role in regulating intestinal inflammation and gut microbial dysbiosis. This review summarizes the pathogenesis and underlying molecular mechanisms of renal fibrosis associated with GM dysbiosis, providing therapeutic strategies and targets for polysaccharide remodeling of the GM to improve kidney disease. We further systematically present the beneficial effects of natural polysaccharides on kidney disease through various molecular mechanisms, such as Toll-like receptor 4, G-protein-coupled receptors, NOD-, LRR- and pyrin domain-containing protein 3 inflammasome, glucagon-like peptide-1 receptor, IƙB/NF-ƙB and Keap1/Nrf2 signaling pathways via regulating gut microbial-derived metabolites, such as lipopolysaccharide, short-chain fatty acids, and uremic toxins. These studies expand the understanding of the therapeutic effects and underlying molecular mechanism of natural polysaccharides on kidney disease and expound a clear pathophysiological rationale for the treatment of kidney disease. This review provides targeted therapeutic strategies for kidney disease prevention and management by modulating GM, highlighting the potential of natural polysaccharides as prebiotics in clinical practice.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。